# Abhinav Jain > Abhinav Jain is a angel investor at Prognoix backing Health Care. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026. - Type: Angel Investor - Fund: Prognoix - Total investments: 2 - Last investment: Aug 2020 - Lead investor: 0% - Last updated: Sep 2026 Abhinav Jain is a angel investor at Prognoix focused on Health Care and Therapeutics. ## Contacts 5 contacts available for Abhinav Jain: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/abhinav-jain-8803?utm_source=investor_profile ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Health Care | 1 | 50% | | Therapeutics | 1 | 50% | | Medical Device | 1 | 50% | ### Stage | Stage | Investments | Share | | --- | --- | --- | | Angel | 1 | 50% | | Funding Round | 1 | 50% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Prognoix | We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives. | $60K | Angel | Aug 01, 2020 | | | Prognoix | We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives. | $230K | | May 11, 2018 | | 2 of 2 investments shown. ## About Prognoix VC Fund · Singapore, Singapore We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives. 2 contacts available at Prognoix. | Name | Title | Profile | | --- | --- | --- | | Abhinav Jain | Director | https://shizune.co/investors/profile/abhinav-jain-8803 | | Christoph Pies | Chief Medical Officer | https://shizune.co/investors/profile/christoph-pies-9751 | ## Similar investors ### Similar industry - [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund ### Similar stage - [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund - [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund - [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund ### Similar country - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund - [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund ## Featured in investor lists - [Medical Device Angel Investors in Asia](https://shizune.co/investors/medical-device-angel-investors-asia) - [Medical Device Investors in Singapore](https://shizune.co/investors/medical-device-investors-singapore) - [Medical Device Angel Investors in Singapore](https://shizune.co/investors/medical-device-angel-investors-singapore) ## FAQ ### What does Abhinav Jain invest in? Abhinav Jain invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Angel and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### How do I contact Abhinav Jain? For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox. ### When did Abhinav Jain last invest? The most recent investment recorded for Abhinav Jain closed in Aug 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co